2,032
Total Claims
$262K
Drug Cost
298
Beneficiaries
$878
Cost/Patient
Peer Comparison vs. 218,535 Nurse Practitioner providers
-25%
Cost per patient vs peers
$878 vs $1,174 avg
+62%
Brand preference vs peers
14.3% vs 8.9% avg
Brand vs Generic
86% generic
Brand: 287 claims · $217K
Generic: 1,716 claims · $44K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 29 | $35K |
| Empagliflozin | 25 | $33K |
| Semaglutide | 20 | $22K |
| Apixaban | 16 | $12K |
| Linagliptin | 13 | $10K |
| Fluticasone Propion/Salmeterol | 19 | $7,871 |
| Solifenacin Succinate | 11 | $3,193 |
| Levothyroxine Sodium | 79 | $1,646 |
| Atorvastatin Calcium | 107 | $1,576 |
| Divalproex Sodium | 12 | $1,413 |
| Albuterol Sulfate | 42 | $1,399 |
| Gabapentin | 42 | $1,352 |
| Levothyroxine Sodium | 18 | $1,107 |
| Losartan Potassium | 45 | $1,045 |
| Fenofibrate,micronized | 13 | $1,039 |
Prescribing Profile
Patient Profile
71
Avg Age
54%
Female
1.47
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data